The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 22, 2022
Filed:
Sep. 13, 2019
Applicant:
Nantomics, Llc, Culver City, CA (US);
Inventors:
Stephen Charles Benz, Santa Cruz, CA (US);
Andrew Nguyen, San Jose, CA (US);
Charles Joseph Vaske, Santa Cruz, CA (US);
John Zachary Sanborn, Santa Cruz, CA (US);
Assignee:
NantOmics, LLC, Culver City, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C12N 5/09 (2010.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01); C07K 16/22 (2006.01); C07K 14/47 (2006.01); A61K 47/68 (2017.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 39/001102 (2018.08); A61K 39/001144 (2018.08); A61K 47/6851 (2017.08); C07K 14/4702 (2013.01); C07K 16/22 (2013.01); C07K 16/30 (2013.01); C12N 5/0638 (2013.01); C12N 5/0646 (2013.01); C12N 5/0693 (2013.01); G01N 33/57407 (2013.01); A61K 2039/505 (2013.01); A61K 2039/53 (2013.01); A61K 2039/80 (2018.08); A61K 2039/812 (2018.08); A61K 2039/892 (2018.08); C07K 2317/34 (2013.01); C07K 2319/55 (2013.01); C07K 2319/60 (2013.01);
Abstract
Certain universal neoepitopes and cancer specific neoepitopes and methods therefore are presented that may be used in immunotherapy and cancer diagnosis. Preferred therapeutic and diagnostic compositions include antibodies or fragments thereof that bind to neoepitopes on cancer cells.